Equity Details
Price & Market Data
Price: $21.14
Daily Change: -$0.26 / 1.23%
Daily Range: $20.93 - $21.72
Market Cap: $2,307,853,056
Daily Volume: 1,013,884
Performance Metrics
1 Week: -5.54%
1 Month: -4.90%
3 Months: 21.82%
6 Months: 80.85%
1 Year: 228.1%
YTD: 58.03%
About Definium Therapeutics, Inc. (DFTX)
Access a quick overview of Definium Therapeutics, Inc. (DFTX). Trading at 21.14, the stock recorded a daily change of -$0.26 / 1.23%. Its market cap is 2,307,853,056. Discover its performance over 3 months (21.82%) and 6 months (80.85%).
Company Details
Employees: 106
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.